Furthermore, transfer of 1 x 106 Glut1T-KO T cells significantly improved long term survival in majority of recipients compared to both TCDBM + BCL1 and WT T cell recipients, which all died from tumor or GVHD (Figures 4A–E). This evidence concerns the gene CCND1 and graft versus host disease.